Scroll Top
Gain Therapeutics Inc.

Gain Therapeutics Begins Promising Parkinson’s Phase 1b Study

Clinical Trial Vanguard

Sep 19, 2025

Gain Therapeutics Begins Promising Parkinson’s Phase 1b Study

 

Latest Articles

Clear Filters
December 18, 2025
Two Molecules Show Potential in Targeting GCase Activity for Parkinson’s Disease Treatment
https://www.geneonline.com/two-molecules-show-potential-in-targeting-gcase-activity-for-parkinsons-disease-treatment/
Read More
December 13, 2025
AI and Physics-Based Modeling Identifies a New Parkinson’s Disease Drug
https://www.the-scientist.com/ai-and-physics-based-modeling-identifies-a-new-parkinson-s-disease-drug-73851
Read More
October 9, 2025
In the clinic for Oct. 9, 2025
https://www.bioworld.com/articles/724982-in-the-clinic-for-oct-9-2025
Read More